762192-22-3Relevant academic research and scientific papers
THIAZOLE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS
-
Page/Page column 83, (2008/06/13)
The invention encompasses compounds of Formula I (I) or pharmaceutically acceptable salts thereof, which are antagonist of the CXCR3 chemokine receptor useful for the treatment or prevention of pathogenic inflammatory processes, autoimmune diseases or graft rejection processes. Methods of use and pharmaceutical compositions are also encompassed.
